Cognitive and academic outcomes in long-term survivors of infantile-onset Pompe disease: A longitudinal follow-up.

作者: Gail A. Spiridigliozzi , Lori A. Keeling , Mihaela Stefanescu , Cindy Li , Stephanie Austin

DOI: 10.1016/J.YMGME.2017.04.014

关键词:

摘要: This study examines the long-term cognitive and academic outcomes of 11 individuals with infantile onset Pompe disease (IOPD) (median age=11years, 1month, range=5years, 6months through 17years age) treated enzyme replacement therapy from an early age. All participants (7 males, 4 females) were administered individual intelligence tests (Wechsler or Leiter scales both), a measure their skill levels (Woodcock-Johnson Tests Achievement), screening visual-motor integration ability (Beery-Buktenica). Consistent our earlier findings, median IQ scores for entire group on Wechsler (median=84) (median=92) continue to fall at lower end average range compared same-aged peers. The (median=76), visual perception (median=74) motor coordination (median=60) below average. Two distinct subgroups emerged based participants' performance majority subtests. Those skills (n=6) demonstrated nonverbal abilities Leiter, but had weaknesses in speech language greater medical involvement. Their profiles more consistent learning disability diagnosis than intellectual disability. these showed significant decline (15 23 points, respectively) repeated scales, one continued earn where verbal demands are minimal. Participants (n=5) (verbal nonverbal) less appeared be intact. However, both groups earned Beery-Buktenica task. highlights importance using appropriate capture abilities, considering each individual's skills, hearing status native language. will allow accurate assessment whether there is Long-term may related stability expressive and/or receptive over time. Changes domain account observed some IOPD survivors, reflecting rather overall cognition These observations, conjunction neuroimaging, further understanding neurocognitive profile survivors.

参考文章(27)
Nancy Mather, Barbara J. Wendling, Woodcock-Johnson III Tests of Achievement. John Wiley & Sons Inc. ,(2009)
Alexandra A Beckemeyer, Priya S Kishnani, New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond. Pediatric endocrinology reviews. pp. 114- 124 ,(2014)
Ron Dumont, John O. Willis, Kathleen Veizel, Jamie Zibulsky, Wechsler Intelligence Scale for Children–Fourth Edition Encyclopedia of Special Education. ,(2014) , 10.1002/9781118660584.ESE2522
Susan A. Sullivan, Leiter International Performance Scale–Revised Psychology in the Schools. ,vol. 35, pp. 195- 197 ,(1998) , 10.1002/(SICI)1520-6807(199804)35:2<195::AID-PITS14>3.0.CO;2-7
Edward Yang, Sanjay P. Prabhu, Imaging Manifestations of the Leukodystrophies, Inherited Disorders of White Matter Radiologic Clinics of North America. ,vol. 52, pp. 279- 319 ,(2014) , 10.1016/J.RCL.2013.11.008
N. Weisglas-Kuperus, J. Jaeken, M. H. Lequin, W. F. M. Arts, A. T. van der Ploeg, B. J. Ebbink, F. K. Aarsen, C. M. van Gelder, J. M. P. van den Hout, Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy Neurology. ,vol. 78, pp. 1512- 1518 ,(2012) , 10.1212/WNL.0B013E3182553C11
Yin-Hsiu Chien, Ni-Chung Lee, Shinn-Forng Peng, Wuh-Liang Hwu, Brain Development in Infantile-Onset Pompe Disease Treated by Enzyme Replacement Therapy Pediatric Research. ,vol. 60, pp. 349- 352 ,(2006) , 10.1203/01.PDR.0000233014.84318.4E
Gail A. Spiridigliozzi, James H. Heller, Laura E. Case, Harrison N. Jones, Priya S. Kishnani, Early cognitive development in children with infantile Pompe disease. Molecular Genetics and Metabolism. ,vol. 105, pp. 428- 432 ,(2012) , 10.1016/J.YMGME.2011.10.012